Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Origin BioMed Inc.
WARNING LETTER
•Origin BioMed Inc.

Origin BioMed Inc. – FDA Warning Letter

Record Details

The FDA issued a Warning Letter to Origin BioMed Inc. following a review of their website, social media accounts (Facebook, Twitter), and product labels for "Neuragen PN" and "Neuragen Cream." The FDA determined that these products are misbranded drugs under sections 503(b) and 301 of the FD&C Act.

The misbranding stems from numerous labeling claims establishing the products' intended use for treating severe, disabling nerve pain, including conditions like diabetic neuropathy, shingles, and fibromyalgia. Examples of claims include "topical treatment for severe, disabling nerve pain," "effective in relieving pain in a variety of nerve related conditions," and "clinically shown to reduce neuropathic (nerve) pains quickly." The products' name, "neuragen," also implies an association with nerve pain.

These claims classify "Neuragen PN" and "Neuragen Cream" as drugs intended for the diagnosis, cure, mitigation, treatment, or prevention of disease, or to affect the body's structure/function. The FDA asserts they are prescription drugs under section 503(b)(1) because they treat conditions requiring physician diagnosis and treatment. Consequently, they are misbranded under section 503(b)(4) for failing to bear the "Rx only" symbol.

While recognized as homeopathic drugs, the FDA states that homeopathic products are subject to the same regulatory requirements as other drugs and are not exempt from misbranding rules.

Company
Origin BioMed Inc.
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Howard Sklamberg (Partner)
View Company Profile

ID · 44be33ce-2d8a-4eba-82cb-0c9e1c84d005

Violation Codes6
21 U.S.C. 353(b)(1)21 U.S.C. 353(b)21 U.S.C. 33121 U.S.C. 321(g)(1)21 U.S.C. 353(b)(4)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Origin BioMed Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.